Open AccessEfficacy and safety of dapagliflozin plus saxagliptin vs monotherapy as added to metformin in patients with type 2 diabetes
Author(s) -
Yan Zhuang,
Jin Song,
Miaofa Ying,
Mingxing Li
Publication year - 2020
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000021409
Subject(s) - dapagliflozin , medicine , saxagliptin , metformin , type 2 diabetes , randomized controlled trial , adverse effect , diabetes mellitus , type 2 diabetes mellitus , weight loss , gastroenterology , endocrinology , insulin , obesity , sitagliptin